USA Financial Formulas’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2
Closed -$1.01K 539
2023
Q3
$1.01K Hold
2
﹤0.01% 398
2023
Q2
$1.04K Hold
2
﹤0.01% 367
2023
Q1
$1.15K Buy
+2
New +$1.13K ﹤0.01% 286
2022
Q3
$1K Hold
2
﹤0.01% 277
2022
Q2
$1K Hold
2
﹤0.01% 304
2022
Q1
$1K Sell
2
-2,045
-100% -$1.17M ﹤0.01% 335
2021
Q4
$1.37M Buy
+2,047
New +$1.28M 1.17% 50
2021
Q2
Sell
-172
Closed -$78K 444
2021
Q1
$78K Sell
172
-2,616
-94% -$1.25M 0.06% 182
2020
Q4
$1.3M Sell
2,788
-791
-22% -$371K 1.03% 33
2020
Q3
$1.58M Buy
+3,579
New +$1.48M 1.19% 30
2017
Q4
Sell
-18,348
Closed -$3.47M 340
2017
Q3
$3.47M Buy
+18,348
New +$3.32M 0.83% 43

Other funds holding TMO

USA Financial Formulas's TMO Position: Q4 2023 in Review

USA Financial Formulas sold out of Thermo Fisher Scientific (TMO) in Q4 2023, closing a stake of 2 shares — an estimated $1.01K sold.

USA Financial Formulas first reported a position in TMO in Q3 2017 and held it in 11 quarters. The position peaked at $3.47M in Q3 2017. 2,491 funds tracked by Wall St. Rank hold TMO as of Q4 2023.

  • USA Financial Formulas reported no remaining Thermo Fisher Scientific position as of Q4 2023 after selling out during the quarter.
  • USA Financial Formulas sold 2 Thermo Fisher Scientific shares in Q4 2023, an estimated $1.01K.
  • USA Financial Formulas first reported a position in Thermo Fisher Scientific in Q3 2017 and held it in 11 quarters.
  • USA Financial Formulas's Thermo Fisher Scientific position peaked at $3.47M in Q3 2017.
  • 2,491 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.

Based on USA Financial Formulas's 13F filing for Q4 2023, filed 7 Feb 2024.